ARVO Advocacy Day: A Powerful Voice for Vision Research
ARVO’s 2026 Advocacy Day was a tremendous success, bringing together researchers, clinicians, patient advocates, and emerging scientists from across the vision community to engage directly with Members of Congress and their staff on Capitol Hill.
Throughout the day, advocates shared firsthand insights into the importance of sustained federal investment in vision research and the critical role of the National Eye Institute in driving discoveries that prevent blindness and restore sight. These conversations help ensure policymakers understand how research advances not only improve patient outcomes but also strengthen innovation and economic growth.
With a record number of advocates participating, this year’s Advocacy Day demonstrated the strength and unity of the vision research community. By elevating scientific expertise and patient perspectives in policy discussions, participants helped reinforce why vision research must remain a national priority.
Thank you to ARVO and all the advocates who dedicated their time and passion to advancing the future of sight.
“Advocacy Day shows the power of the vision community coming together to ensure policymakers understand how federal investment in research drives discoveries that prevent blindness and restore sight. When researchers and patients share their stories directly with Congress, it makes the impact of vision research impossible to ignore.”
Dan Ignaszewski, Executive Director of Alliance for Vision Research
Related News & Events
Lorem ipsum dolor sit amet, consectetur adipiscing elit.
A Powerful Moment for Vision Science: Reflections from the “Impact of Vision Science” Convening
On March 24, the Alliance for Vision Research joined leaders from across the vision community at a remarkable convening hosted by Research to Prevent Blindness, titled “The Impact of Vision Science.” Bringing together experts spanning research, clinical care, industry, philanthropy, and advocacy, the event underscored both the extraordinary progress being made in vision science and … Continued
Advancing Glaucoma Research on Capitol Hill
Alliance for Vision Research recently convened a Congressional Briefing on glaucoma, bringing together researchers, clinicians, advocates, and policymakers to highlight the latest scientific advances and the urgent need for sustained federal investment in vision research. While more intimate in size, the briefing delivered meaningful impact—fostering powerful conversations and connections between experts and congressional staff. Speakers … Continued
Advancing AMD Research and Elevating Patient Voices
In a recent Congressional Briefing focused on Age-Related Macular Degeneration (AMD), leaders in research and patient advocacy came together to highlight both the latest scientific advances and the real-world impact of this leading cause of vision loss. The program featured Rajendra S. Apte, MD, PhD, Paul A. Cibis Distinguished Professor at Washington University School of … Continued